# Foundation Medicine

FoundationOne CDx and FoundationOne Liquid CDx carry stacked FDA companion-diagnostic approvals (Tepmetko/tepotinib in MET exon-14-skipping NSCLC; Talzenna/talazoparib with Xtandi/enzalutamide in HRR-mutated mCRPC; Akeega/niraparib-abiraterone in BRCA-positive mCRPC),…

Source: https://en.bioecon.ru/companies/foundation-medicine/
Updated: 2026-08-15

- Country: United States

## Technologies

- [Liquid biopsy & ctDNA diagnostics](https://en.bioecon.ru/technology/liquid-biopsy-ctdna-diagnostics/)